Evidence map›Paper›PMID 41549131›Full record

ArticleScientific reports2026

Formulation of bacterial cellulose nanofibrils incorporated with xanthone as functional green ingredients for cosmeceutical products.

Sanattapon Kongtaveesombat, Selorm Torgbo, Nuntaporn Kamonsutthipaijit, Bandhita Wanikorn, Prakit Sukyai

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sanattapon KongtaveesombatCellulose for Future Materials and Technologies Special Research Unit, Department of Biotechnology, Kasetsart University, Chatuchak, Bangkok, 10900, Thailand.
Selorm TorgboCellulose for Future Materials and Technologies Special Research Unit, Department of Biotechnology, Kasetsart University, Chatuchak, Bangkok, 10900, Thailand.
Nuntaporn KamonsutthipaijitSynchrotron Research and Applications Division, Synchrotron Light Research Institute, Nakhon Ratchasima, 30000, Thailand.
Bandhita WanikornDepartment of Biotechnology, Kasetsart University, Chatuchak, Bangkok, 10900, Thailand.
Prakit SukyaiCellulose for Future Materials and Technologies Special Research Unit, Department of Biotechnology, Kasetsart University, Chatuchak, Bangkok, 10900, Thailand. fagipks@ku.ac.th.

Funding

Kasetsart University Research and Development Institute FF(KU) 51.67
6 · The paper itself

Abstract

This study developed a bio-based gel using bacterial cellulose nanofibrils (BCNF) as a natural moisturizing and delivery matrix, and xanthone, an active ingredient from Garcinia mangostana peel, with known antimicrobial, anti-inflammatory, and antioxidant properties. BCNF was produced through a mechanical defibrillation process, resulting in nanofibers with an average diameter of 32.12 ± 2.54 nm. FTIR and WAXS analyses confirmed successful Xanthone incorporation into the BCNF matrix. The composite demonstrated moderate anti-inflammatory activity, inhibiting albumin denaturation with an IC50 value of 33.00 ± 2.72 mg/mL and nitric oxide inhibition of 28.66 ± 3.75% similar to triamcinolone acetonide, at the concentration of 1 mg/mL. Antibacterial assays revealed effective inhibition of Cutibacterium acnes and Staphylococcus aureus, with MIC values of 0.976 and 3.906 mg/mL, respectively. The acne gel formulated with BCNF/Xanthone showed stable antioxidant activity over 30 days, as evaluated by DPPH assay. Overall, the formulation 4 (F4), which used BCNF/Xanthone as the sole stabilizer and bioactive carrier showed the highest free radical scavenging activity and killing efficiency against S. aureus. Rheological assessments confirmed that BCNF/Xanthone enhanced gel viscosity and resulted in non-Newtonian, shear-thinning flow behavior, and stable pH value after 30 days, suitable for topical application. These findings suggest that BCNF/Xanthone offer a sustainable, effective alternative with multifunctional benefits for acne management.

Indexed as

CelluloseCosmeticsNanofibersXanthonesAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsMicrobial Sensitivity TestsPropionibacterium acnesStaphylococcus aureusAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsCelluloseCosmeticsxanthoneXanthonesAnti-acne gelAntibacterial activityAnti inflammatoryBacterial cellulose nanofibrilsXanthone

Identifiers

PMID41549131
PMCPMC12887036

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.